292 related articles for article (PubMed ID: 33809978)
1. Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297-391) Intermediates.
Maina MB; Al-Hilaly YK; Burra G; Rickard JE; Harrington CR; Wischik CM; Serpell LC
Cells; 2021 Mar; 10(3):. PubMed ID: 33809978
[TBL] [Abstract][Full Text] [Related]
2. Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.
Maina MB; Al-Hilaly YK; Oakley S; Burra G; Khanom T; Biasetti L; Mengham K; Marshall K; Harrington CR; Wischik CM; Serpell LC
J Mol Biol; 2022 Oct; 434(19):167785. PubMed ID: 35961386
[TBL] [Abstract][Full Text] [Related]
3. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
[TBL] [Abstract][Full Text] [Related]
4. Dityrosine cross-linking and its potential roles in Alzheimer's disease.
Maina MB; Al-Hilaly YK; Serpell LC
Front Neurosci; 2023; 17():1132670. PubMed ID: 37034163
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures.
Davis DR; Anderton BH; Brion JP; Reynolds CH; Hanger DP
J Neurochem; 1997 Apr; 68(4):1590-7. PubMed ID: 9084430
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
7. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
[TBL] [Abstract][Full Text] [Related]
8. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
Wang JZ; Grundke-Iqbal I; Iqbal K
Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
[TBL] [Abstract][Full Text] [Related]
10. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
Shin RW
Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
[TBL] [Abstract][Full Text] [Related]
11. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
12. Early events in copper-ion catalyzed oxidation of α-synuclein.
Tiwari MK; Leinisch F; Sahin C; Møller IM; Otzen DE; Davies MJ; Bjerrum MJ
Free Radic Biol Med; 2018 Jun; 121():38-50. PubMed ID: 29689296
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
14. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking.
Al-Hilaly YK; Pollack SJ; Vadukul DM; Citossi F; Rickard JE; Simpson M; Storey JMD; Harrington CR; Wischik CM; Serpell LC
J Mol Biol; 2017 Nov; 429(23):3650-3665. PubMed ID: 28919235
[TBL] [Abstract][Full Text] [Related]
16. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.
Yan SD; Yan SF; Chen X; Fu J; Chen M; Kuppusamy P; Smith MA; Perry G; Godman GC; Nawroth P
Nat Med; 1995 Jul; 1(7):693-9. PubMed ID: 7585153
[TBL] [Abstract][Full Text] [Related]
17. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
18. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Weaver CL; Espinoza M; Kress Y; Davies P
Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
[TBL] [Abstract][Full Text] [Related]
19. beta-Amyloid induces paired helical filament-like tau filaments in tissue culture.
Ferrari A; Hoerndli F; Baechi T; Nitsch RM; Götz J
J Biol Chem; 2003 Oct; 278(41):40162-8. PubMed ID: 12893817
[TBL] [Abstract][Full Text] [Related]
20. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.
Lovell MA; Xiong S; Xie C; Davies P; Markesbery WR
J Alzheimers Dis; 2004 Dec; 6(6):659-71; discussion 673-81. PubMed ID: 15665406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
